- Home
- WEST vs TRVI Comparison
WEST vs TRVI Comparison
Compare WEST & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- TRVI
- Stock Information
- Founded
- WEST 2009
- TRVI 2011
- Country
- WEST United States
- TRVI United States
- Employees
- WEST N/A
- TRVI N/A
- Industry
- WEST Beverages (Production/Distribution)
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- WEST Consumer Staples
- TRVI Health Care
- Exchange
- WEST Nasdaq
- TRVI Nasdaq
- Market Cap
- WEST 640.7M
- TRVI 725.7M
- IPO Year
- WEST N/A
- TRVI 2019
- Fundamental
- Price
- WEST $6.65
- TRVI $7.41
- Analyst Decision
- WEST Strong Buy
- TRVI Strong Buy
- Analyst Count
- WEST 5
- TRVI 9
- Target Price
- WEST $10.60
- TRVI $19.94
- AVG Volume (30 Days)
- WEST 297.3K
- TRVI 1.8M
- Earning Date
- WEST 08-07-2025
- TRVI 08-11-2025
- Dividend Yield
- WEST N/A
- TRVI N/A
- EPS Growth
- WEST N/A
- TRVI N/A
- EPS
- WEST N/A
- TRVI N/A
- Revenue
- WEST $872,022,000.00
- TRVI N/A
- Revenue This Year
- WEST $22.72
- TRVI N/A
- Revenue Next Year
- WEST $14.75
- TRVI N/A
- P/E Ratio
- WEST N/A
- TRVI N/A
- Revenue Growth
- WEST 2.38
- TRVI N/A
- 52 Week Low
- WEST $5.28
- TRVI $2.36
- 52 Week High
- WEST $10.10
- TRVI $8.11
- Technical
- Relative Strength Index (RSI)
- WEST 51.41
- TRVI 61.65
- Support Level
- WEST $6.86
- TRVI $7.31
- Resistance Level
- WEST $7.31
- TRVI $7.74
- Average True Range (ATR)
- WEST 0.27
- TRVI 0.41
- MACD
- WEST 0.04
- TRVI 0.05
- Stochastic Oscillator
- WEST 49.62
- TRVI 56.21
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.